Wandercraft announced that the U.S. Food and Drug Administration (FDA) has granted clearance for Eve, its personal self-balancing exoskeleton designed to support upright mobility in everyday life. For eligible wheelchair users, Wandercraft says the clearance opens new possibilities beyond rehabilitation, bringing hands-free upright mobility into ordinary moments that may hold extraordinary meaning. For many wheelchair users, opportunities to s…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.